Advancing the Management of Cancer-Related Bone Disease

Bone is the most common site of cancer metastasis, and bone metastases are often involved in advanced breast and prostate cancer. Fractures are a serious consequence of bone metastases and are predictors of poor survival in cancer. This symposium focuses on the current state of the art in the treatment and prevention of cancer-related bone loss, fracture, and bone metastases, and also features a discussion on how the pathophysiology of bone disease is informing the development of new therapies.